FDA Staff Flag Renal Risk of Diabetes Drug

(MedPage Today) -- The novel type 2 diabetes drug canagliflozin (Invocana) is effective at lowering blood glucose, but FDA reviewers have raised concerns about renal and fracture risks. via MedPageToday.com - medical news plus CME for physicians Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/01/fda-staff-flag-renal-risk-of-diabetes.html